Leukotrienes are dispensable for vaginal neutrophil recruitment as part of the immunopathological response during experimental vulvovaginal candidiasis
Leukotrienes are dispensable for vaginal neutrophil recruitment as part of the immunopathological response during experimental vulvovaginal candidiasis
Recruitment of polymorphonuclear neutrophils (PMNs) into the vaginal lumen is the hallmark of an acute immunopathologic inflammatory response during vulvovaginal candidiasis (VVC) caused by Candida albicans. Recurrent VVC (RVVC) remains a chronic health burden in affected women worldwide despite the use of antifungal therapy. Based on the role leukotrienes (LTs) play in promoting inflammation, leukotriene receptor antagonists (LTRAs) targeted for LTB4 (etalocib) or LTC4, LTD4, and LTE4 (zafirlukast or montelukast) have been shown to reduce inflammation of epithelial tissues. An open-label pilot study using long-term regimens of zafirlukast in women with RVVC indicated the potential for some relief from recurrent episodes. To investigate this clinical observation further, we evaluated the effects of LT antagonistic agents and LT deficiency on the immunopathogenic response in a mouse model of VVC. Results showed that mice given daily intraperitoneal injections of individual LTRAs, starting 2days prior to vaginal inoculation with C. albicans and continuing through 14days post-inoculation, had no measurable reduction in PMN migration. The LTRAs were also ineffective in reducing levels of the hallmark vaginal inflammatory markers (S100A8, IL-1β) and tissue damage (LDH) associated with the immunopathogenic response. Finally, LT-deficient 5-lipoxygenase knockout mice showed comparable levels of vaginal fungal burden and PMN infiltration to wild-type mice following inoculation with a vaginal (ATCC 96113) or laboratory (SC5314) C. albicans isolate. These results indicate that despite some clinical evidence suggestive of off-target efficacy of LTRAs in RVVC, LTs and associated signaling pathways appear to be dispensable in the immunopathogenesis of VVC.
Candida albicans, immunopathology, inflammatory responses, leukotriene receptor antagonists, vulvovaginal candidiasis
Yano, Junko
5bcab2ca-0946-4208-88c1-ebec2de9b17a
White, David J
6601d838-319b-470a-a475-bee478e8a04d
Sampson, Anthony P
4ca76f6f-ff35-425d-a7e7-c2bd2ea2df60
Wormley, Floyd L
92f6c42d-0ee2-40a3-b773-c12a69b6b233
Fidel, Paul L
b74d326e-4040-4207-9c30-75e6c4e9579c
17 November 2021
Yano, Junko
5bcab2ca-0946-4208-88c1-ebec2de9b17a
White, David J
6601d838-319b-470a-a475-bee478e8a04d
Sampson, Anthony P
4ca76f6f-ff35-425d-a7e7-c2bd2ea2df60
Wormley, Floyd L
92f6c42d-0ee2-40a3-b773-c12a69b6b233
Fidel, Paul L
b74d326e-4040-4207-9c30-75e6c4e9579c
Yano, Junko, White, David J, Sampson, Anthony P, Wormley, Floyd L and Fidel, Paul L
(2021)
Leukotrienes are dispensable for vaginal neutrophil recruitment as part of the immunopathological response during experimental vulvovaginal candidiasis.
Frontiers in Microbiology, 12, [739385].
(doi:10.3389/fmicb.2021.739385).
Abstract
Recruitment of polymorphonuclear neutrophils (PMNs) into the vaginal lumen is the hallmark of an acute immunopathologic inflammatory response during vulvovaginal candidiasis (VVC) caused by Candida albicans. Recurrent VVC (RVVC) remains a chronic health burden in affected women worldwide despite the use of antifungal therapy. Based on the role leukotrienes (LTs) play in promoting inflammation, leukotriene receptor antagonists (LTRAs) targeted for LTB4 (etalocib) or LTC4, LTD4, and LTE4 (zafirlukast or montelukast) have been shown to reduce inflammation of epithelial tissues. An open-label pilot study using long-term regimens of zafirlukast in women with RVVC indicated the potential for some relief from recurrent episodes. To investigate this clinical observation further, we evaluated the effects of LT antagonistic agents and LT deficiency on the immunopathogenic response in a mouse model of VVC. Results showed that mice given daily intraperitoneal injections of individual LTRAs, starting 2days prior to vaginal inoculation with C. albicans and continuing through 14days post-inoculation, had no measurable reduction in PMN migration. The LTRAs were also ineffective in reducing levels of the hallmark vaginal inflammatory markers (S100A8, IL-1β) and tissue damage (LDH) associated with the immunopathogenic response. Finally, LT-deficient 5-lipoxygenase knockout mice showed comparable levels of vaginal fungal burden and PMN infiltration to wild-type mice following inoculation with a vaginal (ATCC 96113) or laboratory (SC5314) C. albicans isolate. These results indicate that despite some clinical evidence suggestive of off-target efficacy of LTRAs in RVVC, LTs and associated signaling pathways appear to be dispensable in the immunopathogenesis of VVC.
Text
fmicb-12-739385
- Version of Record
More information
Accepted/In Press date: 27 October 2021
Published date: 17 November 2021
Keywords:
Candida albicans, immunopathology, inflammatory responses, leukotriene receptor antagonists, vulvovaginal candidiasis
Identifiers
Local EPrints ID: 453934
URI: http://eprints.soton.ac.uk/id/eprint/453934
ISSN: 1664-302X
PURE UUID: b8df02f6-5afe-49c8-9f3d-ff4855d5a09e
Catalogue record
Date deposited: 25 Jan 2022 18:25
Last modified: 17 Mar 2024 02:43
Export record
Altmetrics
Contributors
Author:
Junko Yano
Author:
David J White
Author:
Floyd L Wormley
Author:
Paul L Fidel
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics